Definition
Strategic autonomy (autonomie stratégique) is a European policy concept articulating the goal of reducing Europe’s — and France’s — dependence on external powers for critical capabilities, technologies, supply chains, and strategic goods. The concept emerged from European defense policy discussions in the 1990s but has expanded dramatically since 2016 into economic, technological, health, and energy domains. Strategic autonomy does not imply autarky or the elimination of international trade and cooperation; it implies maintaining sufficient independent capacity that no external power can coerce Europe by threatening to restrict access to critical inputs.
Role in France 2030
Strategic autonomy is the European-level framing that France 2030 is operationalizing at national scale. While sovereignty is France’s domestic articulation of this agenda — asserting France’s right and responsibility to maintain industrial capabilities independent of market forces — strategic autonomy positions this agenda within a European geopolitical context. France has been the most consistent and ambitious advocate for European strategic autonomy across multiple domains, and France 2030 is the most concrete national implementation of this vision.
The strategic autonomy agenda has been repeatedly validated by geopolitical shocks that France and other EU advocates had anticipated. Russia’s weaponization of natural gas exports following its 2022 invasion of Ukraine demonstrated energy strategic autonomy’s importance. COVID-19 vaccine shortages demonstrated health strategic autonomy’s importance. The US CHIPS Act’s domestic content requirements and TSMC’s Taiwan vulnerabilities demonstrated semiconductor strategic autonomy’s importance. Each shock has strengthened the political case for France 2030’s sovereignty investments and accelerated European policy convergence around strategic autonomy objectives.
France’s advocacy for strategic autonomy has shaped EU policy in concrete ways: the IPCEI framework (allowing member states to fund strategic industrial projects beyond normal state aid limits), the European Chips Act, the Critical Raw Materials Act, the Net Zero Industry Act, and the European Defence Fund all reflect France’s strategic autonomy agenda transposed to European level. This means that France 2030’s national investments are consistently amplified by European-level programs that France helped design.
Key Facts
- Strategic autonomy concept originated in EU defense policy; expanded to economic and technological domains post-2016
- France has been the EU’s most consistent strategic autonomy advocate under Presidents Hollande and Macron
- Key vulnerabilities addressed: energy (gas from Russia), health (vaccines from Asia), semiconductors (chips from Taiwan/Korea), digital (cloud from US)
- France 2030 is explicitly framed as implementing strategic autonomy at national level
- EU policies shaped by France’s strategic autonomy agenda: IPCEI, European Chips Act, Critical Raw Materials Act, Net Zero Industry Act
- Germany has historically resisted strategic autonomy arguments; 2022 Russia-Ukraine war significantly changed German position
Why It Matters
For investors and corporate strategists, strategic autonomy is not rhetorical — it is a genuine policy driver that shapes where France 2030 money flows. Projects that reduce dependencies (domestic semiconductor manufacturing, European cloud infrastructure, domestic vaccine production) receive higher political priority than projects that create new dependencies. Companies that can credibly articulate their contribution to European strategic autonomy objectives are more likely to win France 2030 competitions and receive maximum funding support.
For multinational corporations making location decisions, France’s strategic autonomy doctrine creates both an opportunity and a constraint. The opportunity: companies that bring genuinely autonomous capabilities to France — proprietary technology, supply chain control, workforce training — are welcomed with substantial public investment. The constraint: companies perceived as creating dependency (joint ventures with Chinese state enterprises, technology licensing arrangements with unfavorable terms, infrastructure investments that could be leveraged for coercion) face regulatory barriers and political resistance.